The difficult decision-making process for using or not using adjuvant chemotherapy in premenopausal endocrine-responsive breast cancer patients.
Del Mastro
L
L
Oncologia Medica A, Istituto Nazionale per la Ricerca sul, Cancro, L.go R. Benzi 10, 16132 Genoa, Italy. Electronic address: lucia.delmastro@istge.it.
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D017024:Chemotherapy, Adjuvant; D003657:Decision Making; D005260:Female; D017273:Goserelin / Q000627:therapeutic use*; D006801:Humans; D017697:Premenopause; D011379:Prognosis; D016019:Survival Analysis; D013629:Tamoxifen / Q000627:therapeutic use*
D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen; D017273:Goserelin